Skip to main content
Clinical Trials/IRCT2016091929508N4
IRCT2016091929508N4Completed未知

The effect of psyllium oral supplementation on insulin resistance and lipid profile in non diabetic patients with polycystic ovary syndrome

Vice chancellor for research, Urmia University of Medical Sciences0 sites54 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
54

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 45 years (—)
Sex
Female

Inclusion Criteria

  • Age range 18-45 years; PCOs diagnosis based on the Rotterdam; Persons with fasting glucose concentrations in the range of less than 126 mg /dl; Exclusion criteria: Smoker or addict; Individuals receiving glucose-lowering drugs other than Metformin; Corticosteroid consumer; Consumer drugs such as Lithium, Carbamazepine and Digoxin; Warfarin consumer; Individuals with a history of Myocardial Infarction, Kidney, Liver and Lung diseases; Individuals with Thyroid Dysfunction; Individuals with major surgery in the last 6 months; Individuals with a history of allergy to Psyllium and Aspartame; Patients with Phenylketonuria; Patients with type 1 diabetes, Gastrectomy and Parkinson's disease; Individuals with a history of Gastrointestinal Disease, particularly persistent constipation and narrowing and blockage of the intestinal tract; Individuals treated with drugs that affect blood lipid profile; Individuals with a history of diseases such as Congenital Adrenal Hyperplasia, Cushing's syndrome, Hyperprolactinemia, the androgen-secreting tumors and Thyroid disease; Patients treated with antidepressant medications and recent treatment for eating disorder; Individuals treated with other fiber supplements.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice chancellor for research, Urmia University of Medical Sciences

Similar Trials

The effect of psyllium oral... | Clinical Trial